Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChoiceSpine develops and markets FDA-cleared spinal implant systems—including titanium and PEEK interbody devices, pedicle screw systems, SI joint fixation screws, and biologic kits—designed to improve outcomes in open and minimally invasive spine surgery. The company has recently launched a robotics-integrated app with eCential Robotics to enhance surgical precision. Its Blackhawk® Ti system received standalone FDA clearance in September 2023 for anterior cervical procedures. No clinical trial data typical of drug development companies; product efficacy supported by regulatory clearances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChoiceSpine.